Press release
Infectious Disease Diagnostics Market Projected to Reach $42.20 Billion by 2030
According to MarketsandMarkets Trademark , The report " Infectious Disease Diagnostics Market [https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, PCR, NGS), Disease (Hepatitis, HIV, HAI, TB, Flu, Syphilis), End User (Labs)- Global Forecast to 2030", is projected to reach USD 42.20 billion by 2030 from USD 26.58 billion in 2025, at a CAGR of 9.7% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Browse
* 537 Market Data Tables
* 59 Figures
* 448 Pages and in-depth TOC on "Infectious Disease Diagnostics Market - Global Forecast to 2030".
Some of the prominent key players are:
* F. Hoffmann-La Roche Ltd. (Switzerland),
* Abbott (US),
* Danaher Corporation (US),
* bioMerieux (France),
* Thermo Fisher Scientific Inc. (US),
* Siemens Healthineers AG (Germany),
* Becton, Dickinson and Company (US),
* Hologic, Inc. (US) and many more......
Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Infectious Disease Diagnostics Market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
* By product & service, the market is segmented into reagents, kits, and consumables; instruments; and software & services. In 2024, the reagents, kits, and consumables segment accounted for the largest share of the market. The large share of this segment is attributed to the high volume of these products required for routine testing. Unlike instruments, consumable purchases are recurring, leading to consistent demand among end users.
* The infectious disease diagnostics market has been segmented based on sample type into blood, serum, and plasma; urine; and other sample types. In 2024, the blood, serum, and plasma segment accounted for the largest share of the infectious disease diagnostics market, by sample type. These samples offer a rich & diverse source of diagnostic information for infectious diseases.
* Based on technology, the infectious disease diagnostics market is broadly segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing, DNA microarray, and other technologies. Immunodiagnostics growth is driven by rapid, reliable assays suitable for high-throughput and POC testing.
* Based on clinical application, the infectious disease diagnostics market has been segmented into diagnostic and screening. Diagnostic testing is fueled by the need to confirm infections, guide treatment decisions, and monitor disease progression.
* The infectious disease diagnostics market is segmented into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest share of the market. The region's leadership is primarily driven by a well-established diagnostics landscape, with the US as the key contributor.
The growth of the infectious disease diagnostics market is primarily driven by the increasing incidence & prevalence of infectious diseases globally, coupled with the growing emphasis on early detection and timely treatment. The emergence of novel pathogens, recurring outbreaks, and the threat of antimicrobial resistance have further highlighted the need for accurate and rapid diagnostic solutions. Advancements in diagnostic technologies, including molecular & point-of-care platforms, have significantly improved test performance, accessibility, and turnaround times. Additionally, healthcare expenditure growth, diagnostic infrastructure expansion in emerging economies, and supportive government initiatives to strengthen disease surveillance are contributing to the market growth.
Related Reports:
Veterinary Infectious Disease Diagnostics Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221816584&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2030
Respiratory Care Devices Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=368&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=infectious-disease-diagnostics-market-projected-to-reach-4220-billion-by-2030]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Diagnostics Market Projected to Reach $42.20 Billion by 2030 here
News-ID: 4444030 • Views: …
More Releases from ABNewswire
Petroleum Resin/hydrocarbon resin: Focusing on Tangshan Saiou Chemical Co., Ltd.
In the ever-changing field of industrial materials, petroleum resin (also known as hydrocarbon resins) occupy an important market position due to their wide range of applications and unique properties. These synthetic resins, polymerized from petroleum fractions, are increasingly widely used in various industries such as adhesives, coatings, inks, and rubber products. Tangshan Saiou Chemical Co., Ltd. is one of the leading companies in this field and has become a leader…
2026 Global Wire Trim Cutting Tape Market Trends & Industry Update By CONPAIN GR …
Image: https://ecdn6.globalso.com/upload/p/3469/image_other/2026-04/1-21.jpg
Market Overview & Industry Changes 2026
In 2026, the global Wire Trim Cutting Tape [https://www.copa-tape.com/wire-trim-cutting-tape/] market maintains steady growth, driven by the booming automotive refinishing, truck bed liner, and industrial coating industries. More professional workshops and factories prioritize efficient, clean-edge trimming solutions, making wire trim cutting tape an essential product for modern surface treatment.
Key industry changes include higher demand for strong cutting performance, residue-free removal, good durability, and eco-friendly materials.…
Aluminum Corner Brackets: Unsung Heroes of Residential Door and Window Systems
Image: https://ecdn6.globalso.com/upload/p/4259/image_other/2025-12/aluminum-corner-brackets.jpg
Aluminum Corner Brackets
Residential buildings stand as the primary application arena for aluminum corner brackets, lightweight yet robust components that are indispensable in casement windows, sliding windows, swing doors, and sliding doors. Crafted from high-grade aluminum alloys, these small yet vital parts undertake two core missions: securely connecting frame profiles at corners and reinforcing critical stress-bearing points, directly safeguarding the structural integrity and long-term performance of residential Door And Window…
YINENG PHARMA Chairman Yi Yueneng Appears at the 2026 J.P. Morgan Healthcare Con …
In January, as the tides of the Pacific signal new directions for the global biopharmaceutical industry, the 44th J.P. Morgan Healthcare Conference successfully concluded on January 15, 2026, in San Francisco.
As one of the largest healthcare investment and industry collaboration events worldwide, this "industry barometer" gathered over 8,000 participants, including global industry leaders, more than 500 listed companies, thousands of startups, and technology innovators to explore emerging trends and partnership…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
